BVAS/WG vs CAPTIV8 Share
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
BVAS/WG
Read full descriptionHide full description
BVAS scale is a tool in the form of a questionnaire designed to measure the severity of the diseases from group of vasculitis. „BVAS/WG” is a shortened version of the scale. It is used to evaluate the activity of Wegener's granulomatosis. Our free application is a convenient way to benefit from BVAS scale, at any time, without filling out printed forms. Application consists of 9 major modules (and additional „Other”), which represent groups of organs and systems. In each group are listed symptoms. They can be assigned respectively 1 or 3 points (1 is called. small symptom, 3 - big symptom). Before making any medical decisions, besides using the application, be sure to consult a doctor. Data source: http://api.lekseek.com/mobile/bvas/BVAS.pdf
CAPTIV8 Share
Easily share medical animations with patients via SMS or email. This app also enables secure telemedicine consultations and posting animations to social media. It requires a paid subscription for use by eye care professionals.
- Share patient animations via SMS/email
- Secure telemedicine consultations
- Post animations to social media
- Patient education tool
- HIPAA compliant
Read full descriptionHide full description
CAPTIV8 Share allows you to easily send patients CAPTIV8 animations to via SMS or email. CAPTIV8 Share requires a paid subscription, it is for Ophthalmologists and Optometrists as part of their consultation and patient education. CAPTIV8 Share will also enable clinicians to perform fully compliant and secure Telemedicine consultations. Finally, as part of this new release, clinicians can also post animations to their social media channels.
Screenshots
Verdict
The clearest difference is update cadence: CAPTIV8 Share at monthly against BVAS/WG's every 11 months. BVAS/WG's advantage is iOS requirement (9.0 vs 18.6). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
BVAS/WG ships an update every 11 months, CAPTIV8 Share monthly. The most recent releases landed on October 16, 2026 and October 8, 2026 respectively.
| Parameter | BVAS/WG | CAPTIV8 Share |
|---|---|---|
| Price | Free | Free |
| Rating | — | 1.0 (1 ratings) — better |
| Number of ratings | — | 1 — better |
| Update frequency | Every 11 months | Monthly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | — | Subscription |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 9.0 — better | 18.6 |
| Further details — not scored | ||
| Size | 12 MB | 35 MB |
| Age rating | 17+ | 12+ |
| Developer | LekSeek Polska Sp. z o.o. | Optimed Limited |
In-app purchases
BVAS/WG
No in-app purchases
CAPTIV8 Share
No in-app purchases
